Arrive Health, in partnership with AWS and a leading Integrated Delivery Network, Launches Innovative Generative AI-Powered Solution to Accelerate Medication Access

DENVER, Jan. 21, 2025 /PRNewswire/ — Arrive Health, a leader for the past decade in real-time prescription benefits, today announced the expansion of their medication access solutions with the launch of arrive ACCELERATE.  arrive ACCELERATE harnesses the power of generative AI to streamline the prior authorization process, enabling choice to drive faster time to therapy and improved patient outcomes. Developed in collaboration with Amazon Web Services (AWS) and a world-renowned healthcare delivery system and insurer, this cutting-edge solution is now live at over 25 provider sites.

The arrive ACCELERATE solution seamlessly integrates with electronic medical record (EMR) systems, providing AI-generated guidance on medication coverage requirements to accelerate the electronic prior authorization (ePA) workflow. This streamlined approach aims to minimize provider confusion, prior authorization denials, therapy delays and administrative burden. By accelerating time to fill through in-workflow automation tools, providers are empowered to expedite care delivery, all within the familiar EMR environment. This innovative solution will help providers navigate the prescribing process by bringing health plan coverage insights to the prior authorization process.

Looking ahead, Arrive Health remains dedicated to driving meaningful change in the healthcare industry through continued innovation and strategic partnerships. “Clearing the way to better health means empowering the patient and provider encounter with the right information the first time.  Our vision is to equip providers with the tools they need to deliver the highest quality of care, while ensuring patients have seamless access to medications they can afford,” said Kyle Kiser, Arrive Health CEO. “With arrive ACCELERATE, that vision is becoming a reality for millions of patients and the providers they trust.”

Ultimately, Arrive Health’s mission is to empower healthcare providers with the tools and resources they need to deliver exceptional patient care, while ensuring that patients have timely access to the medications they require. By combining innovative technology, strategic partnerships, and a patient-centric approach, Arrive Health is poised to drive transformative change and shape the future of healthcare delivery.

About Arrive Health: Arrive Health is a leader in medication access solutions, dedicated to improving patient outcomes and reducing provider burden through technology-driven innovation. With a focus on collaboration and actionable insights, Arrive Health is committed to simplifying the healthcare experience for all. For more information, visit www.arrivehealth.com

Media Contact:
Asha Strazzero-Wild, asha@outpointe.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/arrive-health-in-partnership-with-aws-and-a-leading-integrated-delivery-network-launches-innovative-generative-ai-powered-solution-to-accelerate-medication-access-302355743.html

SOURCE Arrive Health

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

23 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

23 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

23 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

23 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

23 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

23 hours ago